CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-01-27 | Ahn Mark J President & CEO | Option exercise · Stock Option | −121,875 | 423,173 | ||
| 2014-01-23 | KRIEGSMAN STEVEN A Director | Option exercise | +100,000 | $1.18 | $118K | 105,000 |
| 2014-01-23 | KRIEGSMAN STEVEN A Director | Option exercise | +50,000 | $2.31 | $116K | 155,000 |
| 2014-01-23 | KRIEGSMAN STEVEN A Director | Sale | −150,000 | $5.92 | $889K | 5,000 |
| 2014-01-23 | KRIEGSMAN STEVEN A Director | Option exercise · Stock Option (right to buy) | −100,000 | 0 | ||
| 2014-01-23 | KRIEGSMAN STEVEN A Director | Option exercise · Stock Option (right to buy) | −50,000 | 0 | ||
| 2014-01-22 | KRIEGSMAN STEVEN A Director | Option exercise | +200,000 | $1.18 | $236K | 205,000 |
| 2014-01-22 | KRIEGSMAN STEVEN A Director | Option exercise | +50,000 | $0.72 | $36K | 255,000 |
| 2014-01-22 | KRIEGSMAN STEVEN A Director | Sale | −250,000 | $6.13 | $1.5M | 5,000 |
| 2014-01-22 | KRIEGSMAN STEVEN A Director | Option exercise · Stock Option (right to buy) | −200,000 | 0 | ||
| 2014-01-22 | KRIEGSMAN STEVEN A Director | Option exercise · Stock Option (right to buy) | −50,000 | 0 | ||
| 2014-01-17 | Hillsberg Sanford Director | Sale | −200,000 | $6.93 | $1.4M | 110,447 |
| 2014-01-17 | KRIEGSMAN STEVEN A Director | Option exercise | +200,000 | $0.85 | $170K | 205,000 |
| 2014-01-17 | KRIEGSMAN STEVEN A Director | Sale | −200,000 | $7.00 | $1.4M | 5,000 |
| 2014-01-17 | KRIEGSMAN STEVEN A Director | Option exercise · Stock Option (right to buy) | −200,000 | 0 | ||
| 2014-01-17 | Nisi Rudolph Director | Sale | −200,000 | $6.90 | $1.4M | 3,500 |
| 2014-01-15 | Nisi Rudolph Director | Option exercise | +100,000 | $1.18 | $118K | 103,500 |
| 2014-01-15 | Nisi Rudolph Director | Option exercise | +100,000 | $0.85 | $85K | 203,500 |
| 2014-01-15 | Nisi Rudolph Director | Option exercise · Stock Option (right to buy) | −100,000 | 0 | ||
| 2014-01-15 | Nisi Rudolph Director | Option exercise · Stock Option (right to buy) | −100,000 | 0 |
Page 16 of 17 · 324 trades